Understanding what to expect at each stage of escalation helps you distinguish between normal adaptation and signals that something is wrong
Discuss your symptomswhether it's the frustration of weight you can't lose or the "brain fog" that won't lift
Obesity is considered a chronic condition and GLP-1 medications are intended for long-term use Evidence shows that stopping the medication often leads to weight regain Many patients remain on therapy indefinitely, similar to treatments for other chronic conditions (e.g., hypertension or diabetes), provided the medication is effective and well tolerated Periodic reassessment ensures the treatment remains appropriate and beneficial GLP-1 Agonists: A Powerful Tool for Sustainable Weight Management One of the most exciting advancements Ive seen in clinical practice is the use of GLP-1 receptor agonists medications that are transforming how we approach obesity and metabolic health
In the future, it might be used for more intense therapies for cancer treatment and other conditions
In clinical trials, patients lost about 12% of their body weight over 72 weeks and also saw improvements in blood pressure and cholesterol
Retatrutide hits threeGIP, GLP-1, and glucagonsimultaneously
